Nanologica: Securing growth capital

Research Note

2024-01-30

11:57

Redeye leaves its comments on Nanologica following today’s news that it has announced a fully guaranteed SEK54.2m rights issue intended to enhance production efficiency and sales.

FE

Filip Einarsson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.